Drug Type Small molecule drug |
Synonyms Metronidazole hydrochloride (USAN), Asuzol + [1] |
Target- |
Action inhibitors |
Mechanism DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Nov 1980), |
Regulation- |
Molecular FormulaC6H10ClN3O3 |
InChIKeyFPTPAIQTXYFGJC-UHFFFAOYSA-N |
CAS Registry69198-10-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05016 | Metronidazole Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacterial Infections | United States | - | 28 Nov 1980 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | Jordan | - |
Phase 3 | 586 | (1% SPL7013 Gel) | ceezbeiusy(rfldckqvrt) = opewtaagwf xlhyfwlvpr (zipyzrieyt, iwwocwevzk - skdbynblfl) View more | - | 09 Jul 2019 | ||
Placebo gel+Metronidazole oral tablets 500mg (Placebo Gel) | ceezbeiusy(rfldckqvrt) = zouwzniyoa xlhyfwlvpr (zipyzrieyt, orjzlnzlwi - okikepttvu) View more |